-
Mashup Score: 3
BACKGROUND: Varying rates of nonsustained ventricular tachycardia (NSVT) have been reported early after transcatheter pulmonary valve replacement (TPVR) with the Harmony valve, but data regarding rhythm outcomes beyond hospital discharge are limited. This study aims to characterize ventricular arrhythmias after Harmony TPVR from implant through mid-term follow-up. METHODS: Ventricular arrhythmia data from postimplant telemetry and follow-up extended rhythm monitoring (ERM) were analyzed after Harmony TPVR. RESULTS: Fifty-four patients with tetralogy of Fallot (n=39), valvar pulmonary stenosis (n=10), or pulmonary atresia with intact ventricular septum (n=5) were studied; 22% had prior NSVT and 24% were on prior rhythm medication. On postimplant telemetry, 27 patients (50%) had NSVT, including 1 who had torsade de pointes, but most had <5 episodes. Pre-TPVR NSVT or rhythm medications, diagnosis other than tetralogy, and substantial device contact with the myocardium were associated with
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 150
BACKGROUND: In patients with previous coronary artery bypass grafting, computed tomography cardiac angiography (CTCA) before invasive coronary angiography (ICA) was demonstrated in the BYPASS-CTCA trial (Randomized Controlled Trial to Assess Whether Computed Tomography Cardiac Angiography Can Improve Invasive Coronary Angiography in Bypass Surgery Patients) to reduce procedure time and incidence of contrast-associated acute kidney injury, with greater levels of patient satisfaction. Patient-related outcomes, utilization of further diagnostic imaging resources, and longer-term incidence of major adverse cardiac events were key secondary end points not yet reported. METHODS: Patients with prior coronary artery bypass grafting referred for ICA were randomized 1:1 to undergo CTCA before ICA or ICA alone and followed up for a median of 3 (2.2-3.4) years. Angina status was assessed using the Seattle Angina Questionnaire and overall quality of life using the EQ-5D-5L. The incidence of noninva
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
Is CT Coronary Angiography prior to invasive coronary angiography in patients with prior bypass surgery of benefit? 3-year results from the BYPASS-CTCA Trial @matt_kelham @AnneMarieBeirn1 @BhcIntervention #cardiotwitter #AHAJournals https://t.co/9v03sV2qST https://t.co/4jrDy9xloT
-
-
Mashup Score: 141
BACKGROUND: In patients with previous coronary artery bypass grafting, computed tomography cardiac angiography (CTCA) before invasive coronary angiography (ICA) was demonstrated in the BYPASS-CTCA trial (Randomized Controlled Trial to Assess Whether Computed Tomography Cardiac Angiography Can Improve Invasive Coronary Angiography in Bypass Surgery Patients) to reduce procedure time and incidence of contrast-associated acute kidney injury, with greater levels of patient satisfaction. Patient-related outcomes, utilization of further diagnostic imaging resources, and longer-term incidence of major adverse cardiac events were key secondary end points not yet reported. METHODS: Patients with prior coronary artery bypass grafting referred for ICA were randomized 1:1 to undergo CTCA before ICA or ICA alone and followed up for a median of 3 (2.2-3.4) years. Angina status was assessed using the Seattle Angina Questionnaire and overall quality of life using the EQ-5D-5L. The incidence of noninva
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
Is CT Coronary Angiography prior to invasive coronary angiography in patients with prior bypass surgery of benefit? 3-year results from the BYPASS-CTCA Trial @matt_kelham @AnneMarieBeirn1 @BhcIntervention #cardiotwitter #AHAJournals https://t.co/9v03sV2qST https://t.co/4jrDy9xloT
-
-
Mashup Score: 23
View all available purchase options and get full access to this article. Scotti A, Fovino LN, Coisne A, Fabris T, Cardaioli F, Massussi M, Rodinò G, Barolo A, Boiago M, Continisio S, et al. 10-year impact of transcatheter aortic valve replacement leaflet design (intra- versus supra-annular) in mortality and hemodynamic performance. Front Cardiovasc Med. 2022;:924958. doi: 10.3389/fcvm.2022.924958 Herrmann HC, Mehran R, Blackman DJ, Bailey S, Möllmann H, Abdel-Wahab M, Ben Ali W, Mahoney PD, Ruge H, Wood
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
Do you have a TAVR preference? Self-Expanding vs Balloon Expandable TAVR. @DakroubAH @SarahMalik05 @sellers_steph @David_Meier_ @djc795 @CathElectroSurg #cardiotwitter #AHAJournals https://t.co/Z6am7JYlrh https://t.co/vyoIOlHi3o
-
-
Mashup Score: 7
BACKGROUND: While initial data for transcatheter aortic valve replacement (TAVR) in aortic stenosis patients with mitral stenosis (MS) suggested a poor short-term prognosis, outcomes for contemporary balloon-expandable valves remain unknown. The aim of this retrospective multicenter registry study was to compare the potential impact of MS on TAVR outcomes with balloon-expandable valves. METHODS: Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry and Centers for Medicare & Medicaid Services claims data were used to obtain a cohort of 327 925 patients who underwent TAVR with current balloon-expandable valves (SAPIEN 3, SAPIEN 3 Ultra, or SAPIEN 3 Ultra Resilia) between June 2015 and December 2022 across 791 sites. Severe MS (defined as >10 mm Hg mean gradient or <1.5 cm2 area) was compared with mild or less MS (defined as 2 cm2 area) using propensity matching to minimize confounding variables. RESULTS: Patients w
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
What is the outcome for TAVR with balloon expandable valve in patients with severe mitral stenosis? A report from the TVT Registry @Anirudh_KumarMD @chetanhuded @GrantReedMD @sachingoelmd @docHJ @jamiemccabemd @MayraGuerreroMD @tavrkapadia #cardiotwitter https://t.co/Nc3yAHk8Oz https://t.co/kN8eRUvPgf
-
-
Mashup Score: 12Circulation: Cardiovascular Interventions | AHA/ASA Journals - 2 month(s) ago
Learn the benefits of becoming an AHA/ASA Professional Member and
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet-
With @CRFheart #TCT2023 fast approaching @CircIntv is looking for the next exciting advancement in IC for simultaneous publication. It’s time to take that study and put it into manuscript format. Submit to https://t.co/WQQWlESj3g @TCTconference #AHAJournals #cardiotwitter https://t.co/t5NSsfgN8q
-
-
Mashup Score: 5AHA24 - 2 month(s) ago
Download the mobile program today to easily access event session s, speakers, exhibitors, and organizer messages. Use the native app to personalize your schedule, take notes, share contacts, and more. Build your schedule directly on your computer. Then, install the native app and sync your schedule to your mobile
Source: eppro01.ativ.meCategories: General Medicine News, CardiologistsTweet-
Join @CircIntv editors @SVRaoMD & @JDawnAbbott1 at #AHA24. Circulation: CV Interventions 2023-2024 Editors' Picks: The Best and What's Next Sun, Nov 17 @ 8-9:15am Moderators: Jinnette D Abbott, Sunil V Rao Room: S103D https://t.co/nCL8YNUiLs
-
-
Mashup Score: 19
BACKGROUND: The clinical impact of a chronic total occlusion (CTO) in patients with 3-vessel coronary artery disease undergoing fractional flow reserve–guided percutaneous coronary intervention (PCI) with current-generation drug-eluting stents or coronary artery bypass grafting (CABG) is unclear. METHODS: The FAME 3 trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation 3) compared fractional flow reserve–guided PCI with CABG in patients with 3-vessel coronary artery disease. The primary end point was major adverse cardiac and cerebrovascular events, a composite of death, myocardial infarction, stroke, or repeat revascularization at 1 year. In this substudy, the 3-year outcomes were analyzed in patients with or without a CTO. RESULTS: Of the patients randomized to PCI or CABG in the FAME 3 trial, 305 (21%) had a CTO. In the PCI arm, revascularization of the CTO was attempted in 61% with a procedural success rate of 88%. The incidence of major adverse cardiac and c
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
How does the presence of a CTO effect outcomes in FFR guided therapy for 3-vessel CAD? A comparison of PCI versus CABG. A FAME-3 Substudy @HisaoOtsuki @T_Takahashi_MD @wfearonmd #cardiotwitter #AHAJournals https://t.co/g9tRM9tWSi https://t.co/AOZJe8o5sa
-
-
Mashup Score: 5AHA24 - 2 month(s) ago
Download the mobile program today to easily access event session s, speakers, exhibitors, and organizer messages. Use the native app to personalize your schedule, take notes, share contacts, and more. Build your schedule directly on your computer. Then, install the native app and sync your schedule to your mobile
Source: eppro01.ativ.meCategories: General Medicine News, CardiologistsTweet-
Join @CircIntv editors @SVRaoMD & @JDawnAbbott1 at #AHA24. Circulation: CV Interventions 2023-2024 Editors' Picks: The Best and What's Next Sun, Nov 17 @ 8-9:15am Moderators: Jinnette D Abbott, Sunil V Rao Room: S103D https://t.co/nCL8YNUiLs
-
-
Mashup Score: 1
BACKGROUND: Mitral annular calcification with valve dysfunction remains a challenging syndrome. Operative risk is high, and available transcatheter therapies are limited. METHODS: This study describes our initial experience with a novel procedure to address large mitral annuli when no surgical or trial-based transcatheter mitral valve replacement device is available. The rationale was to shorten the intercommissural distance using commissural mitral transcatheter edge-to-edge repair (TEER) followed by valve-in-mitral annular calcification transcatheter mitral valve replacement with a balloon-expandable aortic valve platform. Patients with long intercommissural distances and large mitral annulus areas were selected based on a high perceived risk of transcatheter valve embolization. Patients underwent mitral TEER with MitraClip in a commissural position, followed immediately by transseptal transcatheter mitral valve replacement with a 29 mm SAPIEN 3 valve. RESULTS: Thirteen patients were
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
Annular Reduction by Cinching with TEER in the Commissure (ARCTIC) TMVR. A hybrid mitral valve procedure for large mitral annuli @jamiemccabeMD @davidelison1 @gb_mackensen @richardsheuMD @loganlvincent #cardiotwitter #AHAJournals https://t.co/l9PYJxeYOR https://t.co/Mo3K8TFo3D
-
Ventricular arrhythmia after Transcatheter Pulmonary Valve Replacement. Is there a need for extended monitoring? #cardiotwitter #AHAJournals @JeffYangMD https://t.co/2hyZI72v8M https://t.co/Is0ua2ZuRH